Legend Biotech Corp 20-F for FY2022
Legend Biotech Corp (LEGN)
20-F
2023-03-30
For: 2022-12-31
View Original
Added on
April 07, 2026
About this 20-F
Legend Biotech Corp filed this 20-F on March 30, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $117.01M
- up 70.0% from $68.83M a year earlier
- Net loss
- $446.35M
- compared with a net loss of $403.58M a year earlier
- Diluted EPS
- -$1.40
- compared with -$1.43 a year earlier